UPDATE: Danaher Buying Beckman Coulter for $6.8B | GenomeWeb

The story has been updated to include information and comments from a conference call Danaher held this morning.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher has agreed to buy Beckman Coulter in a deal valued at $6.8 billion, the two companies announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

In Science this week: global genetic diversity map, and more.